Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105


Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.

Chao C, Bhatia S, Xu L, Cannavale KL, Wong FL, Huang PS, Cooper R, Armenian SH.

JAMA Netw Open. 2019 Jun 5;2(6):e195536. doi: 10.1001/jamanetworkopen.2019.5536.


Cardiovascular Disease Risk Profiles in Survivors of Adolescent and Young Adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study.

Chao C, Xu L, Bhatia S, Cooper R, Brar S, Wong FL, Armenian SH.

J Clin Oncol. 2016 May 10;34(14):1626-33. doi: 10.1200/JCO.2015.65.5845. Epub 2016 Mar 7.


Increased risk of second malignant neoplasms in adolescents and young adults with cancer.

Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE.

Cancer. 2016 Jan 1;122(1):116-23. doi: 10.1002/cncr.29685. Epub 2015 Oct 6.


Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.

Bright CJ, Reulen RC, Winter DL, Stark DP, McCabe MG, Edgar AB, Frobisher C, Hawkins MM.

Lancet Oncol. 2019 Apr;20(4):531-545. doi: 10.1016/S1470-2045(18)30903-3. Epub 2019 Feb 21.


Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer.

Lau BJ, Goldfarb M.

J Adolesc Young Adult Oncol. 2016 Jun;5(2):201-8. doi: 10.1089/jayao.2015.0052. Epub 2016 Apr 4.


Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Franklin J, Eichenauer DA, Becker I, Monsef I, Engert A.

Cochrane Database Syst Rev. 2017 Sep 13;9:CD008814. doi: 10.1002/14651858.CD008814.pub2. Review.


Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.

Kier MG, Hansen MK, Lauritsen J, Mortensen MS, Bandak M, Agerbaek M, Holm NV, Dalton SO, Andersen KK, Johansen C, Daugaard G.

JAMA Oncol. 2016 Dec 1;2(12):1624-1627. doi: 10.1001/jamaoncol.2016.3651.


Birth Outcomes Among Adolescent and Young Adult Cancer Survivors.

Anderson C, Engel SM, Mersereau JE, Black KZ, Wood WA, Anders CK, Nichols HB.

JAMA Oncol. 2017 Aug 1;3(8):1078-1084. doi: 10.1001/jamaoncol.2017.0029.


Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Applebaum MA, Vaksman Z, Lee SM, Hungate EA, Henderson TO, London WB, Pinto N, Volchenboum SL, Park JR, Naranjo A, Hero B, Pearson AD, Stranger BE, Cohn SL, Diskin SJ.

Eur J Cancer. 2017 Feb;72:177-185. doi: 10.1016/j.ejca.2016.11.022. Epub 2016 Dec 26.


Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.

Lee JS, Padilla B, DuBois SG, Oates A, Boscardin J, Goldsby RE.

Pediatr Blood Cancer. 2015 Jul;62(7):1259-64. doi: 10.1002/pbc.25484. Epub 2015 Mar 25.


Long-term Health Outcomes in Survivors of Childhood Cancer Diagnosed Between 1990 and 2000 in a Large US Integrated Health Care System.

Chao C, Xu L, Bell E, Cooper R, Mueller L.

J Pediatr Hematol Oncol. 2016 Mar;38(2):123-30. doi: 10.1097/MPH.0000000000000492.


Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.

Keegan THM, Kushi LH, Li Q, Brunson A, Chawla X, Chew HK, Malogolowkin M, Wun T.

J Cancer Surviv. 2018 Jun;12(3):388-397. doi: 10.1007/s11764-018-0678-8. Epub 2018 Feb 9.


Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.

Keegan TH, Press DJ, Tao L, DeRouen MC, Kurian AW, Clarke CA, Gomez SL.

Breast Cancer Res. 2013;15(5):R95.


Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.


Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.

Youn P, Milano MT, Constine LS, Travis LB.

Cancer. 2014 Aug 1;120(15):2334-42. doi: 10.1002/cncr.28733. Epub 2014 Apr 18.


Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.

Lee JS, DuBois SG, Boscardin WJ, Wustrack RL, Goldsby RE.

Cancer. 2014 Dec 15;120(24):3987-93. doi: 10.1002/cncr.28936. Epub 2014 Aug 12.


Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.

Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC.

Lancet Oncol. 2018 Dec;19(12):1590-1601. doi: 10.1016/S1470-2045(18)30537-0. Epub 2018 Nov 8. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.


Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC.

Lancet Oncol. 2014 Jul;15(8):841-51. doi: 10.1016/S1470-2045(14)70265-7. Epub 2014 Jun 19.


Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012.

Asgari MM, Moffet HH, Ray GT, Quesenberry CP.

JAMA Dermatol. 2015 Sep;151(9):976-81. doi: 10.1001/jamadermatol.2015.1188.


Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.

Turcotte LM, Whitton JA, Friedman DL, Hammond S, Armstrong GT, Leisenring W, Robison LL, Neglia JP.

J Clin Oncol. 2015 Nov 1;33(31):3568-75. doi: 10.1200/JCO.2015.60.9487. Epub 2015 Aug 10.

Supplemental Content

Support Center